heart failureBackground: The purpose of the Current study was to create a model of myocardial infarction (MI) that is homogeneous in size with a low immediate (24 hours) mortality. Methods and Results: Male and female rats (n = 256) underwent left ventricle (LV) ablation (Ab) by a ...
摘要: Assesses physician's survival predictions for patients with acute congestive heart failure. Patient characterization; Use of calibration curve analysis for judgment reliability; Graphical measure of discrimination; Difficulty in prognoses prediction; Necessity for the improvement of guidelines....
Prediction of Mortality and Morbidity With a 6-Minute Walk Test in Patients With Left Ventricular Dysfunction OBJECTIVE: To study the potential usefulness of the 6-minute walk test, a self-paced submaximal exercise test, as a prognostic indicator in patients with l... DH Weiner,S Yusuf,WJ ...
The function of the right heart chamber and pulmonary pressure are factors that predict mortality, but their practical value – their value for the prediction of the life expectancy - is limited [9,10] . Continuous ambulatory monitoring on the basis of telemetric data transmitted by miniaturized ...
Clark et al3 have suggested that the therapeutic response to inotropic agents in congestive heart failure has been largely disappointing, with an increase in mortality after therapy in certain of these agents. Packer et al4 described an increase in mortality with milrinone; increased mortality with ...
Thus, although milrinone is well tolerated and produces early symptomatic benefits in approximately half of patients with congestive heart failure refractory to conventional therapy, there is no evidence that it improves the high baseline mortality in this disorder....
Congestive heart failure (CHF) is a leading cause of morbidity, hospitalization, and mortality in the United States.1 Despite recent advances in research, the pathogenesis of CHF remains uncertain.2 Microvascular disease has long been suggested as a possible pathogenic factor in the development of ...
Introduction With nearly 500,000 new cases per year and direct costs estimated as high as US$38 billion annually, congestive heart failure (CHF) has become a major priority in modern medicine. This crisis will continue to grow as the population ages, thu
Many advances in the treatment of congestive heart failure (CHF) have resulted in improved survival, and a growing number of such patients are being seen by physicians. Although several interventions have reduced the number of patients dying from progres
Recently, the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM)-Added trial has shown that the addition of candesartan to ACE-inhibitor or other treatment leads to a further clinically important reduction in relevant cardiovascular events in patients with CHF (...